163 related articles for article (PubMed ID: 25672919)
1. Prestroke antiplatelet agents in first-ever ischemic stroke: clinical effects.
Jung JM; Choi J; Eun MY; Seo WK; Cho KH; Yu S; Oh K; Hong S; Park KY
Neurology; 2015 Mar; 84(11):1080-9. PubMed ID: 25672919
[TBL] [Abstract][Full Text] [Related]
2. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
[TBL] [Abstract][Full Text] [Related]
3. Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin.
Kim JT; Park MS; Choi KH; Cho KH; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko YC; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim DE; Ryu WS; Shin DI; Yeo MJ; Kim WJ; Lee J; Lee JS; Saver JL; Bae HJ
Stroke; 2016 Jan; 47(1):128-34. PubMed ID: 26604247
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome.
Park JM; Kang K; Cho YJ; Hong KS; Lee KB; Park TH; Lee SJ; Ko Y; Han MK; Lee J; Cha JK; Kim DH; Kim DE; Kim JT; Choi JC; Yu KH; Lee BC; Lee JS; Lee J; Gorelick PB; Bae HJ;
Ann Neurol; 2016 Apr; 79(4):560-8. PubMed ID: 26754410
[TBL] [Abstract][Full Text] [Related]
5. Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes.
Jung JM; Cha J; Choi J; Eun MY; Seo WK; Oh K; Cho KH; Yu S
Eur Neurol; 2016; 75(1-2):89-95. PubMed ID: 26863137
[TBL] [Abstract][Full Text] [Related]
6. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
7. Treatment with statins and ischemic stroke severity: does the dose matter?
Martínez-Sánchez P; Fuentes B; Martínez-Martínez M; Ruiz-Ares G; Fernández-Travieso J; Sanz-Cuesta BE; Cuéllar-Gamboa L; Díaz-Domínguez E; Díez-Tejedor E
Neurology; 2013 May; 80(19):1800-5. PubMed ID: 23596066
[TBL] [Abstract][Full Text] [Related]
8. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
[TBL] [Abstract][Full Text] [Related]
9. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
10. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
Koton S; Molshatzki N; Bornstein NM; Tanne D
Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
12. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
[TBL] [Abstract][Full Text] [Related]
13. Effect of prestroke antiplatelets use on first-ever ischaemic stroke severity and early outcome.
Bembenek JP; Niewada M; Karlinski M; Czlonkowska A
Int J Clin Pract; 2016 Jun; 70(6):477-81. PubMed ID: 27040605
[TBL] [Abstract][Full Text] [Related]
14. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion.
Ricciardi AC; López-Cancio E; Pérez de la Ossa N; Sobrino T; Hernández-Pérez M; Gomis M; Munuera J; Muñoz L; Dorado L; Millán M; Dávalos A; Arenillas JF
Cerebrovasc Dis; 2014; 37(4):304-11. PubMed ID: 24851928
[TBL] [Abstract][Full Text] [Related]
15. The Interplay between Stroke Severity, Antiplatelet Use, and Aspirin Resistance in Ischemic Stroke.
Agayeva N; Topcuoglu MA; Arsava EM
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):397-403. PubMed ID: 26576697
[TBL] [Abstract][Full Text] [Related]
16. Predictors of vascular events after ischemic stroke: the China ischemic stroke registry study.
Ding D; Lu CZ; Fu JH; Hong Z
Neuroepidemiology; 2010; 34(2):110-6. PubMed ID: 20051694
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
18. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
[TBL] [Abstract][Full Text] [Related]
19. Mild stroke and advanced age are the major reasons for exclusion from thrombolysis in stroke patients admitted within 4.5 hours.
Liu Y; Zhao H; Zhou J; Wang Q; Chen Z; Luo N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1571-6. PubMed ID: 24582787
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
